Ronan C. O'Hagan

关注

立即认领

关注

立即认领

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 31 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

时间

引用量

主题

期刊级别

合作者

合作机构

Supplementary Table S1 from XTX301, a Tumor-Activated Interleukin-12 Has the Potential to Widen the Therapeutic Index of IL12 Treatment for Solid Tumors as Evidenced by Preclinical Studies

Ekta Patel,Natalia V. Malkova,David Crowe,Magali Pederzoli-Ribeil,Damiano Fantini,Manoussa Fanny,Hanumantha Rao Madala,Kurt A. Jenkins,Oleg Yerov,Justin Greene,Wilson Guzman,Caitlin O'Toole,Jacob Taylor,Rebekah K. O'Donnell,Parker Johnson,Bernard B. Lanter,Brian Ames,Jia Chen,Sallyann Vu,Hsin-Jung Wu,Susan Cantin,Megan McLaughlin,Yu-Shan S. Hsiao,Dheeraj S. Tomar,Raphael Rozenfeld,Lakshmanan Thiruneelakantapillai,Ronan C. O'Hagan,Benjamin Nicholson,Jennifer O'Neil,Carl Uli Bialucha

crossref（2024）

引用0浏览0引用

Supplementary Table S3 from XTX301, a Tumor-Activated Interleukin-12 Has the Potential to Widen the Therapeutic Index of IL12 Treatment for Solid Tumors as Evidenced by Preclinical Studies

crossref（2024）

引用0浏览0引用

Supplementary Figure S2 from XTX301, a Tumor-Activated Interleukin-12 Has the Potential to Widen the Therapeutic Index of IL12 Treatment for Solid Tumors As Evidenced by Preclinical Studies

crossref（2024）

引用0浏览0引用

Supplementary Figure S3 from XTX301, a Tumor-Activated Interleukin-12 Has the Potential to Widen the Therapeutic Index of IL12 Treatment for Solid Tumors As Evidenced by Preclinical Studies

crossref（2024）

引用0浏览0引用

Supplementary Figure S5 from XTX301, a Tumor-Activated Interleukin-12 Has the Potential to Widen the Therapeutic Index of IL12 Treatment for Solid Tumors As Evidenced by Preclinical Studies

crossref（2024）

引用0浏览0引用

Supplementary Figure S4 from XTX301, a Tumor-Activated Interleukin-12 Has the Potential to Widen the Therapeutic Index of IL12 Treatment for Solid Tumors As Evidenced by Preclinical Studies

crossref（2024）

引用0浏览0引用

Supplementary Table S2 from XTX301, a Tumor-Activated Interleukin-12 Has the Potential to Widen the Therapeutic Index of IL12 Treatment for Solid Tumors as Evidenced by Preclinical Studies

crossref（2024）

引用0浏览0引用

Data from XTX301, a Tumor-Activated Interleukin-12 Has the Potential to Widen the Therapeutic Index of IL12 Treatment for Solid Tumors As Evidenced by Preclinical Studies

Ekta Patel,Natalia V. Malkova,David Crowe,Magali Pederzoli-Ribeil,Damiano Fantini,Manoussa Fanny,Hanumantha Rao Madala,Kurt A. Jenkins,Oleg Yerov,Justin Greene,Wilson Guzman,Caitlin O'Toole,Jacob Taylor,Rebekah K. O'Donnell,Parker Johnson,Bernard B. Lanter,Brian Ames,Jia Chen,Sallyann Vu,Hsin-Jung Wu,Susan Cantin,Megan Mclaughlin,Yu-Shan S. Hsiao,Dheeraj S. Tomar,Raphael Rozenfeld,Lakshmanan Thiruneelakantapillai,Ronan C. O'Hagan,Benjamin Nicholson,Jennifer O'Neil,Carl Uli Bialucha

MOLECULAR CANCER THERAPEUTICSno. 4 (2024): 421-435

引用0浏览0WOS引用

Supplementary Figure S6 from XTX301, a Tumor-Activated Interleukin-12 Has the Potential to Widen the Therapeutic Index of IL12 Treatment for Solid Tumors As Evidenced by Preclinical Studies

crossref（2024）

引用0浏览0引用

Supplementary Figures S1-3 and Table S1 from 23814, an Inhibitory Antibody of Ligand-Mediated Notch1 Activation, Modulates Angiogenesis and Inhibits Tumor Growth Without Gastrointestinal Toxicity

Theresa A. Proia, Feng Jiang,Alisa Bell,Richard Nicoletti,Lingxin Kong,Kelly Kreuter,Laura L. Poling,William M. Winston,Meghan Flaherty,Solly Weiler,Samantha Perino,Rónán C. O’Hagan, Lin J,Jenő Gyuris,Heidi Okamura

openalex（2023）

引用0浏览0引用

加载更多

作者统计

#Papers: 31

#Citation: 1030

H-Index: 9

G-Index: 13

Sociability: 6

Diversity: 1

Activity: 2

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn